Ian Smith, MD, FRCP, FRCPE, will receive the William L. McGuire Memorial Lecture Award at the 2018 San Antonio Breast Cancer Symposium® (SABCS®), Dec. 4-8.
The McGuire Award was established in 1992 to honor William L. McGuire, MD, who co-founded SABCS in 1977 along with Charles A. Coltman, MD. The title of Smith’s award lecture is “Hold That Scalpel! Using the Tumor to Determine the Treatment.”
Smith, a professor of cancer medicine at The Royal Marsden and the Institute of Cancer Research in London, is being recognized for a lifetime of contributions that changed the direction of oncology in the United Kingdom and worldwide. They include his research and testing of aromatase inhibitors, his pioneering of neoadjuvant endocrine therapy for patients with large, operable cancers, and major contributions to oncology training in the UK.
“The depth and breadth of his career have been stellar,” said Norman Wolmark, MD, chairman and principal investigator of the National Surgical Adjuvant Breast and Bowel Project Foundation and the 2013 McGuire Award Lecturer. “There isn’t one thing that proves seminal. It’s his lifetime contributions to the field that are formidable.”
Smith was involved in the early clinical development of several anticancer drugs that have subsequently proved effective in the clinic, including carboplatin and letrozole. In the last decade he has become increasingly involved in neoadjuvant therapies as a research approach toward individualized treatments for breast cancer.
This is one of the most prestigious awards in the area of breast cancer,” said SABCS Co-Sponsor C. Kent Osborne, MD, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine in Houston. “This year’s winner, like all the nominees, are the premier researchers.”Smith said he was “thrilled” to learn he was the 2018 McGuire Lecture Award recipient, but also “overawed.”
“I thought of the many recipients who have led and indeed defined breast cancer research throughout my career and I genuinely wondered if I had done enough to justify such a wonderful honor,” Smith said. “I have been lucky enough to be involved in important areas of clinical research that have changed practice, and one of the great pleasures of this work has been its collaborative nature.”
Smith is the chief investigator of the UK POETIC Trial, the largest of its kind. He was appointed first chairman of the UK Breast Trials Intergroup and chairman of the British Breast Group. Smith was the Scientific Chairman of the Breast Section of 2012 ESMO, and he has also chaired several national professional bodies including the Association of Cancer Physicians and the Royal College of Physicians Specialist Advisory Committee for Medical Oncology.
“Ian Smith has made a cumulative longitudinal contribution of moving the state of the art forward,” said Wolmark who is a member of the McGuire Award Selection Committee. “That’s not easily done. In this day and age when we’re all recognized for a soundbite, he’s recognized for his consistency.”
Smith’s lecture will be Wednesday, Dec. 5 at 11:15 a.m. in Hall 3.